Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 1 (2004), Issue 4 (November)

1. Intravoxel distribution of DWI decay rates reveals C6 glioma invasion in rat brain.
   Magn Reson Med, 52(5): 994-1004. [Abstract] [Full-text]
2. Putaminal cavernous angioma presenting with hemichorea.
   Mov Disord, 19(11): 1379-80. [Abstract] [Full-text]
3. Epilepsia partialis continua of the abdominal muscles: a detailed electrophysiological study of a case.
   Mov Disord, 19(11): 1375-8. [Abstract] [Full-text]
4. Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours.
   Int J Cancer, 113(1): 116-25. [Abstract] [Full-text]
5. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
   Eur J Nucl Med Mol Imaging, 31(11): 1464-70. [Abstract] [Full-text]
6. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
   Cancer Res, 64(21): 8009-14. [Abstract] [Full-text]
7. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
   Cancer Res, 64(21): 7794-800. [Abstract] [Full-text]
8. Notch1 and notch2 have opposite effects on embryonal brain tumor growth.
   Cancer Res, 64(21): 7787-93. [Abstract] [Full-text]
9. Risk factors for brain relapse in patients with metastatic breast cancer.
   Ann Oncol, 15(11): 1640-4. [Abstract] [Full-text]
10. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Int J Radiat Oncol Biol Phys, 60(4): 1314-24. [Abstract] [Full-text]
11. Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene.
    Eur J Cancer, 40(16): 2525-32. [Abstract] [Full-text]
12. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors.
    Neurologist, 10(6): 293-310. [Abstract] [Full-text]
13. Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation.
    Surgery, 136(5): 1083-7. [Abstract] [Full-text]
14. Intracranial relapse in Wilms tumor patients.
    Pediatr Blood Cancer, 43(7): 737-41. [Abstract] [Full-text]
15. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model.
    Cancer Gene Ther, 11(11): 721-32. [Abstract] [Full-text]
16. Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma.
    Cancer Gene Ther, 11(11): 713-20. [Abstract] [Full-text]
17. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    J Endocrinol, 183(2): 385-94. [Abstract] [Full-text]
18. Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function.
    J Clin Endocrinol Metab, 89(11): 5649-54. [Abstract] [Full-text]
19. Diagnosis of metastatic carcinoma to the cavernous sinus by computed tomograpy-guided fine-needle aspiration.
    Am J Ophthalmol, 138(5): 864-6. [Abstract] [Full-text]
20. Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells.
    Int Immunopharmacol, 4(14): 1775-84. [Abstract] [Full-text]
21. Suprasellar germ cell tumor with subarachnoid seeding MRI and MR spectroscopy findings.
    Clin Imaging, 28(6): 404-7. [Abstract] [Full-text]
22. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
    Exp Neurol, 190(2): 478-85. [Abstract] [Full-text]
23. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
    Cancer, 101(10): 2303-8. [Abstract] [Full-text]
24. Adult glioma incidence trends in the United States, 1977-2000.
    Cancer, 101(10): 2293-9. [Abstract] [Full-text]
25. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Cancer, 101(10): 2318-26. [Abstract] [Full-text]
26. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
    Clin Cancer Res, 10(21): 7182-91. [Abstract] [Full-text]
27. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
    Clin Cancer Res, 10(21): 7163-70. [Abstract] [Full-text]
28. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
    Arthritis Rheum, 50(11): 3616-8. [Abstract] [Full-text]
29. Interferon-gamma induced medulloblastoma in the developing cerebellum.
    J Neurosci, 24(45): 10074-83. [Abstract] [Full-text]
30. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
    Genes Chromosomes Cancer, 42(1): 68-77. [Abstract] [Full-text]
31. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    J Clin Oncol, 22(22): 4551-60. [Abstract] [Full-text]
32. Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties.
    J Virol, 78(23): 12987-95. [Abstract] [Full-text]
33. Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer.
    Lung Cancer, 46(3): 357-60. [Abstract] [Full-text]
34. Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.
    J Inorg Biochem, 98(12): 2168-73. [Abstract] [Full-text]
35. Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival.
    Neuropathol Appl Neurobiol, 30(6): 608-14. [Abstract] [Full-text]
36. Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation.
    Cell Death Differ, 11(12): 1326-41. [Abstract] [Full-text]
37. Localisation and William Macewen's early brain surgery Part I: the controversy.
    J Hist Neurosci, 13(4): 297-325. [Abstract] [Full-text]
38. The diaphragma sellae meningioma -- a rare differential diagnosis of non-functioning pituitary adenoma.
    Zentralbl Neurochir, 65(4): 195-7. [Abstract] [Full-text]
39. Identification of human brain tumour initiating cells.
    Nature, 432(7015): 396-401. [Abstract] [Full-text]
40. Reduced immunoglobulin E and allergy among adults with glioma compared with controls.
    Cancer Res, 64(22): 8468-73. [Abstract] [Full-text]
41. SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
    Cancer Res, 64(22): 8292-8. [Abstract] [Full-text]
42. Role of synaptojanin 2 in glioma cell migration and invasion.
    Cancer Res, 64(22): 8271-5. [Abstract] [Full-text]
43. Volatile anesthetics inhibit calcitonin gene-related peptide receptor-mediated responses in pithed rats and human neuroblastoma cells.
    J Pharmacol Exp Ther, 311(3): 1016-22. [Abstract] [Full-text]
44. Adaptation of a standard low-field (0.3-T) system to the operating room: focus on pituitary adenomas.
    Neurosurg Clin N Am, 16(1): 155-64. [Abstract] [Full-text]
45. A low-field intraoperative MRI system for glioma surgery: is it worthwhile?
    Neurosurg Clin N Am, 16(1): 135-41. [Abstract] [Full-text]
46. Diffusion tensor magnetic resonance imaging of brain tumors.
    Neurosurg Clin N Am, 16(1): 115-34. [Abstract] [Full-text]
47. Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis.
    Neurosurg Clin N Am, 16(1): 101-14, vi. [Abstract] [Full-text]
48. Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate.
    Cancer, 101(11): 2614-21. [Abstract] [Full-text]
49. Carcinoid metastasis to the brain.
    Cancer, 101(11): 2605-13. [Abstract] [Full-text]
50. Defining the best available treatment for neurocytomas in children.
    Cancer, 101(11): 2629-32. [Abstract] [Full-text]
51. Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000.
    Klin Padiatr, 216(6): 343-8. [Abstract] [Full-text]
52. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Klin Padiatr, 216(6): 331-42. [Abstract] [Full-text]
53. Differential diagnosis of suprasellar tumors in children.
    Klin Padiatr, 216(6): 323-30. [Abstract] [Full-text]
54. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.
    J Magn Reson Imaging, 20(6): 913-22. [Abstract] [Full-text]
55. Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.
    J Magn Reson Imaging, 20(6): 905-12. [Abstract] [Full-text]
56. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Acta Neurochir (Wien), 146(12): 1323-7; discussion 1327-8. [Abstract] [Full-text]
57. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
    Int J Cancer, 113(3): 379-85. [Abstract] [Full-text]
58. Metastatic adenocarcinoma in the cerebellopontine angle, presenting as a meningioma: a case report of rare occurrence.
    Acta Neurochir (Wien), 146(12): 1369-72; discussion 1372. [Abstract] [Full-text]
59. Strategies for brain shift evaluation.
    Med Image Anal, 8(4): 447-64. [Abstract] [Full-text]
60. Primary central nervous system lymphoma report of 32 cases and review of the literature.
    Clin Neurol Neurosurg, 107(1): 55-63. [Abstract] [Full-text]
61. Altered expression of Cx43 in astrocytic tumors.
    Clin Neurol Neurosurg, 107(1): 49-54. [Abstract] [Full-text]
62. Magnetic source imaging supports clinical decision making in glioma patients.
    Clin Neurol Neurosurg, 107(1): 20-6. [Abstract] [Full-text]
63. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
    Neurosci Res, 50(4): 437-46. [Abstract] [Full-text]
64. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    J Clin Oncol, 22(23): 4795-803. [Abstract] [Full-text]
65. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    J Clin Oncol, 22(23): 4779-86. [Abstract] [Full-text]
66. A clinicobiological model predicting survival in medulloblastoma.
    Clin Cancer Res, 10(22): 7613-20. [Abstract] [Full-text]

© 2004-2010 Brain Tumors Research Today. All Rights Reserved.